Hava David L. 4
4 · Pulmatrix, Inc. · Filed Jun 6, 2018
Insider Transaction Report
Form 4
Pulmatrix, Inc.PULM
Hava David L.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-06-05+795,000→ 795,000 totalExercise: $0.47Exp: 2028-06-05→ Common Stock (795,000 underlying)
Footnotes (1)
- [F1]The option vested as to 25% on June 5, 2018 and the remaining 75% vests in thirty-six (36) equal monthly installments with 2.083% vesting on the last day of each of the next thirty-six (36) months that follow June 5, 2018, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan.